Skip to main content
. 2017 Mar 20;71(3-4):e12901. doi: 10.1111/ijcp.12901

Figure 2.

Figure 2

Trend for reduction in all‐cause mortality in T2DM appears greatest in men over 7533. Mortality in patients categorised by: Group A = normal testosterone; B= low testosterone untreated; C = low testosteron